CODE KENNETH REAY (Chief Science Officer) received a stock award from BIOLARGO, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/2/2026ACC: 0001437749-26-011170
DirectorOfficer10% Owner· Chief Science Officer
Since Jul 2018
+69.44K
Net shares
Net buyer
$11.2K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
69.44K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+69.44K
Price / share
$0.16
Trade value
$11.25K
% of position
0.3%
3/31/2026
25.81M→25.88M
Total
Net shares
+69.44K
Net value
$11.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2026 | A · Award | +69.44K | $0.16 | $11.25K | 0.3% | 25.81M | 25.88M |
| Total | +69.44K | $11.25K | ||||||
Derivative Transactions0
No derivative transactions reported